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Autogenous vaccination reduces 
antimicrobial usage and mortality 
rates in a herd facing severe exudative 
epidermitis outbreaks in weaned pigs
Ioannis Arsenakis,1 Filip Boyen,2 Freddy Haesebrouck,2 Dominiek G D Maes1
This study was conducted in a commercial 1000-sow herd facing recurrent exudative epidermitis (EE) outbreaks 
during the nursery period and assessed the efficacy of autogenous vaccination in controlling such outbreaks. The 
vaccine was produced using three Staphylococcus hyicus isolates recovered from affected pigs shortly before the 
onset of the study. All of those isolates were positive for the exhB gene, which encodes the exfoliative toxin type 
B (ExhB). From four consecutive farrowing batches of sows, two batches were vaccinated (V) against S hyicus at 
five and two weeks before farrowing, and two sow batches remained non-vaccinated (NV). Vaccination efficacy 
was primarily determined by the levels of metaphylactic antimicrobial usage, and the morbidity and mortality 
data for the pigs of the V and NV sows. The total amount of antimicrobials used metaphylactically against EE in 
pigs among the V and NV farrowing batches was 39,600 and 88,550 mg, respectively. The used daily dose pig to 
animal daily dose pig ratio for the V and NV batches were 1.31 and 1.79, respectively (a ratio of 0.8 to 1.2 is in-
dicative of correct dosing). The morbidity and mortality rates were V=6.50 and NV=14.36 (P=0.008), and V=2.59 
and NV=5.02 (P=0.000), respectively. To conclude, autogenous vaccination of the sows with a vaccine based on 
exhB-positive S hyicus isolates reduced metaphylactic treatment with antimicrobials as well as the morbidity and 
mortality rates in weaned pigs compared with pigs from NV sow batches.
Introduction
Exudative epidermitis (EE) is one of the most common 
skin diseases encountered by pigs.1 The primary cause 
of the disease is deemed to be virulent strains of Staphy-
lococcus hyicus that produce exfoliative toxins. So far, a 
total of six toxins have been discovered, namely ExhA, 
ExhB, ExhC and ExhD,2 3 and SHETA and SHETB.4 The 
lesions can be generalised or localised in specific parts 
of the body such as the head and the neck, and are char-
acterised by sebaceous exudation, which then develops 
into epidermal erosions and crusts.5 The most common 
ages affected are suckling and weaned pigs up to six 
weeks of age. In herds facing severe outbreaks of the 
generalised form of EE, progressive dehydration and 
wasting of the affected pigs can be observed, together 
with high mortality rates.5 6 
A very common finding in herds that are affected by 
EE outbreaks is the presence of S hyicus isolates that ex-
hibit broad-spectrum resistance to antimicrobials.7 Re-
ports from several countries have indicated frequent re-
sistance to ceftiofur, penicillin, amoxicillin, ampicillin, 
erythromycin, streptomycin and tetracyclines.8–14 The 
aforementioned presence of resistant S hyicus isolates 
together with the fact that EE can reach morbidity rates 
of up to 90 per cent often complicate the treatment of 
affected pigs, and make it a laborious and economically 
impractical task.9 15
The pig industry is one of the food production sec-
tors with high use of antimicrobials, favouring spread 
of antimicrobial resistance.16 17 Over the years, in sever-
al major pig-producing countries, measures have been 
taken to preserve the efficacy of the currently available 
antimicrobials and to prevent further development of 
antimicrobial resistance.18–20 In this context, there is 
an urgent need to investigate and improve the effica-
cy of alternative solutions for the control of EE under 
field conditions. Such a solution might be vaccination. 
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However, currently no commercial vaccine against S hy-
icus infections is available. Thus, autogenous vaccines 
might be able to fill this gap and contribute to the reduc-
tion of antimicrobial usage. To the authors’ knowledge, 
there are no published studies investigating whether 
autogenous vaccines against S hyicus can reduce anti-
microbial usage during severe EE outbreaks.
The objective of this study was to investigate the 
efficacy of vaccinating gestating sows of a Belgian 
breeding herd facing recurrent outbreaks of EE with an 
autogenous vaccine against S hyicus, to control EE in 
the offspring of those sows. Antimicrobial usage data, 
morbidity and mortality constituted the main effica-
cy parameters. Weight gain and average daily weight 
gain (ADG) were also investigated as secondary efficacy 
parameters.
Materials and methods
Herd and outbreaks description
The study was conducted between October 2015 and 
June 2016 in a commercial Belgian breeding herd with 
1000 sows. The herd operated a four-week batch produc-
tion system for the sows (Table 1). At three weeks of age, 
the pigs were weaned and transferred to two different 
nursery units located on the same site. The first nursery 
unit (N1) consisted of one compartment with eight pens 
(120 pigs per pen), while the second nursery unit (N2) 
consisted of seven compartments of 12 pens each (40 
pigs per pen). N1 had fully slatted floors, a conventional 
mechanical ventilation system (combining vent doors 
and ceiling fans) and a stocking density of 0.26 m2/
pig, whereas each compartment of N2 had fully slatted 
floors, channel ventilation and a stocking density of 
0.24 m2/pig. At 10 weeks of age, all pigs were sold to 
different fattening herds.
Severe and recurrent outbreaks of EE have been re-
ported since June 2014. Clinical signs of EE appeared 
approximately one week after weaning and the sever-
ity of the lesions increased towards the third week of 
the nursery period. No clinical problems requiring 
treatment or any other intervention occurred during 
the suckling period, before or during the study. In Oc-
tober 2015, during a visit to both N1 and N2, almost 
30 per cent of the pigs had clinical signs of EE, while 
the herd owner reported that 100 pigs were culled or 
had died during the previous production batch. These 
losses contributed to an increase of mortality rate from 
approximately 2.5 to 6.7 per cent during the nursery pe-
riod. Moreover, the selling price of the nursery pigs was 
reduced due to the EE-related problems.
From June 2014 until October 2015, the herd vet-
erinarian attempted to treat affected pigs individually 
via intramuscular injections of ceftiofur (Readycef, Lab 
Calier) or sulphadiazine-trimethoprim (Duphatroxim, 
Zoetis), together with spraying and washing with a 
5 per cent weight per volume (w/v) chlorhexidine prod-
uct (Ecutan, Ecuphar). Nevertheless, the response to the 
antimicrobial treatments was poor as EE morbidity and 
the observed mortality rates in the nursery remained 
above 20 and 6 per cent, respectively. In October 2015, 
blood samples were collected from pigs at weaning and 
at seven weeks of age (five for each age group). The se-
rum from the blood samples collected at weaning was 
pooled and tested by real-time PCR for porcine repro-
ductive and respiratory syndrome virus (PRRS(V))-spe-
cific RNA (LSI VetMAX PRRSV EU/NA Real-Time PCR Kit, 
Life Technologies) and by a quantitative PCR for porcine 
circovirus type 2 (PCV2)-specific DNA (ViroReal PCV2, 
Ingenetix). No positive results were obtained for any of 
the above-mentioned viral pathogens. Individual anal-
ysis of the blood samples collected at seven  weeks of 
age showed that 1/5 pigs was seropositive for PRRS(V) 
(HerdCheck PRRS ELISA, IDEXX), while 0/5 pigs was se-
ropositive for PCV2 (IgM and IgG, Ingezim PCV2 ELISA, 
Ingenasa).
In October 2015, the herd was visited for the first 
time by the Unit of Porcine Health Management of the 
Faculty of Veterinary Medicine of Ghent University and 
bacteriological sampling and antimicrobial susceptibil-
ity testing (AST) were performed for the first time. Dur-
ing that visit and in four follow-up visits up to Novem-
ber 2015, skin swabs from the dermis layer (after crusts 
were removed) of 13 affected and non-treated nursery 
Table 1: Herd description and health management practices
Number of sows 1000
Breed of sows Topigs 20
Breed of boars for artificial insemination Piétrain
Vaccination of sows 
  Atrophic rhinitis Rhiniseng (Hipra) four weeks before 
farrowing 
  Escherichia coli + Clostridium novyi/C 
perfringens  type C 
Suiseng (Hipra) three weeks before 
farrowing 
  PRRS(V) Ingelvac PRRS MLV (Boehringer) 
eight weeks before farrowing 
  Swine influenza (type A) Gripovac 3 (Merial) six weeks before 
farrowing 
Vaccination of gilts in quarantine unit 
  Mycoplasma hyopneumoniae Ingelvac MycoFLEX (Boehringer) upon 
entering the unit 
  Parvovirus + Erysipelothrix rhusiopathiae  Parvosuin-MR (Hipra) two times four 
weeks apart 
  PCV2 Ingelvac CircoFLEX (Boehringer) two 
times three weeks apart 
  PRRS(V) Ingelvac PRRS MLV (Boehringer) once 
four weeks before breeding 
  Swine influenza (type A) Gripovac 3 (Merial) two times three 
weeks apart 
Medication of suckling pigs Iron (Prolongal 200, Bayer) on day 3
Long-action ceftiofur (Readycef, Lab 
Calier) on day 3
Vaccination in the nursery unit (days 21–70) 
  PRRS(V) Ingelvac PRRS MLV (Boehringer) on 
day 23 
Medication in the nursery unit (days 21–70), 
before the initiation of the study
In-feed apramycin (Apralan, Elanco) after 
weaning for 14 days
In-feed doxycycline (Doxyral 10%, 
Emdoka) and amoxicillin (Suramox 5%, 
Virbac) for the entire nursery period
PCV2, porcine circovirus type 2; PRRS(V), porcine reproductive and respiratory syndrome virus.
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pigs of one age group were collected and sent for bacteri-
ological culture and AST. Swabs were collected between 
days 10 and 15 of the nursery period, and culture was 
performed within hours of sampling using blood agar 
(5 per cent volume per volume (v/v) sheep blood) and 
a selective/indicative medium for S hyicus.21 22 AST was 
performed using Iso-Sensitest agar (Oxoid, UK) accord-
ing to the Kirby-Bauer disk diffusion method. The an-
timicrobials (Rosco, Denmark) tested are presented in 
Table  2. After 18 hours of aerobic incubation at 37°C, 
inhibition zones were read and interpreted according to 
the manufacturer’s guidelines.23 According to the bac-
teriological culture results, S hyicus was isolated from 
9/13 pigs sampled in total, while Staphylococcus chro-
mogenes was isolated from 1/13 pigs. The differentia-
tion between the S hyicus and S chromogenes isolates 
was performed as described by Andresen et  al.24 The 
AST results of all S hyicus isolates obtained are present-
ed in Table 2. Concerning the single S chromogenes iso-
late obtained, no resistance to any of the antimicrobials 
tested was observed.
Following the aforementioned bacteriological inves-
tigations, the following interventions for the reduction 
of antimicrobial usage were applied: (1) the prophylac-
tic administration of antimicrobials in pigs housed in 
both nursery units (as described in Table 1) was ceased; 
and (2) the metaphylactic treatment of the nursery pigs 
showing clinical signs of EE was continued, however 
only with ceftiofur (intramuscular injection; Readycef, 
Lab Calier). In  addition to the above interventions, it 
was decided to proceed with the production of an au-
togenous vaccine against S hyicus. Five different iso-
lates of S hyicus (5/9 obtained during bacteriological 
culture, from different sampling points) were sent to 
Denmark (DTU Vet, National Veterinary Institute) for 
the typing of the toxins produced. There were no ob-
vious phenotypical differences among those isolates. 
Typing was performed according to Andresen and 
Ahrens,3 and no detection of the exhA, exhC and exhD 
genes occurred in any of the aforementioned isolates. 
In contrast, all isolates were found to be positive for the 
exhB gene, which encodes the exfoliative toxin ExhB 
(type B). Three of those isolates were randomly selected 
and sent to France (Biovac Santé Animale) to produce a 
formaldehyde-inactivated autogenous vaccine against S 
hyicus. The vaccine was produced using only the whole-
cell preparations and not the culture supernatants, and 
was oil-adjuvanted. Importation of the vaccine to Bel-
gium was ‘off-label’, under the cascade regimen defined 
in the European Directive 2001/82/EC as amended by 
Directive 2004/28/EC and by a prescription signed by 
the herd veterinarian.
Experimental design
From four consecutive farrowing batches of sows, two 
batches were vaccinated (V) against S hyicus and two 
remained non-vaccinated (NV). Vaccination of the 
batches was applied in an alternating way, so that each 
non-vaccinated batch was followed by a vaccinated 
batch. All vaccinations were performed by the first 
author. In the V batches, all gilts and sows received 
5 ml of the autogenous vaccine twice, at five and two 
weeks before the expected farrowing date. Vaccinations 
were applied via an intramuscular injection on the 
lateral side of the neck and behind the ear. The different 
farrowing batches participating in the study were named 
as follows: batch A (first batch, NV), batch B (second 
batch, V), batch C (third batch, NV) and batch D (fourth 
batch, V). There were no obvious clinical adverse effects 
observed in the vaccinated sows during the period 
that the study was conducted, such as oedema and/or 
erythematous skin lesions, reduction of feed intake and 
vomiting. In addition, neither the numbers of total and 
liveborn piglets/litter were affected, nor abortions were 
recorded.
Throughout the gestation and suckling period, the 
feed (all in the form of commercial pellet), the feed-
ing schedule and feeding level, the management and 
housing factors, and the remaining vaccinations were 
the same for all batches of sows that participated in 
the study. Upon transfer to the nursery units, pigs were 
partly regrouped according to the farrowing compart-
ment that they originated from and their weight. Ta-
ble 3 presents the distribution of the pigs between N1 
and N2. Both N1 and N2 were managed all-in/all-out by 
compartment, and during the entire study period water 
Table 2: Antimicrobial susceptibility profiles for Staphylococcus  hyicus 
isolates from non-treated pigs with clinical signs of exudative epidermitis, 
before the initiation (n=9) and during the study (n=16)
Number (%) of resistant S hyicus isolates














Table 3: Distribution of the weaned pigs that originated from the different 
farrowing batches (A–D) in each nursery unit
Farrowing batch N1 N2
A Whole unit filled 2
B No pigs placed 4
C Whole unit filled 2
D No pigs placed 4
The total capacity of N1 was 960 pigs, while for N2 it was  3360 pigs. In N2 the numbers represent the 
number of compartments that were fully filled with pigs from each farrowing batch.
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and commercial feed (meal) were supplied ad libitum 
to the pigs. Management factors, sex distribution and 
metaphylactic treatment were kept the same in both N1 
and N2.
Parameters of comparison
For the pigs of each farrowing batch, the following five 
parameters were investigated.
Antimicrobial consumption and morbidity rates
Correctness of metaphylactic antimicrobial dosing 
against EE in nursery pigs was quantified by the used 
daily dose pig (UDDpig) to animal daily dose pig (ADDpig) 
ratio (UDDpig/ADDpig). A ratio of 0.8 to 1.2 is considered 
to be indicative of correct dosing.25 The UDDpig is defined 
as the actual administered dose per day per kg pig of an 
antimicrobial. The average bodyweights at three and ten 
weeks of age and the ADG calculated by the weighing of 
180 randomly selected pigs per batch (see Performance 
parameters) were used to create a standard growth table 
for a given age of the pigs of each batch. The ADDpig is 
the nationally defined average maintenance dose per 
day per kg pig of an antimicrobial.18
The pigs treated against EE within each batch, to-
gether with the dates, the quantity of ceftiofur used 
and the duration of treatment, were recorded. The herd 
owner and the animal caretakers remained blinded 
during the study with respect to whether the piglets 
originated from NV or V sow batches. The number of 
pigs injected with ceftiofur was also used to calculate 
morbidity rates. More specifically, pigs were considered 
to be EE-affected on receiving their first intramuscular 
injection. The standard procedure followed by the herd 
owner to detect EE-affected pigs was applied, that is, in-
spection of all nursery pens twice a day. Pigs that were 
only lightly affected (minor crusts in the head area, with 
no generalised exfoliation of the skin) were not treat-
ed, and thus they were not considered to be affected. 
Before  the initiation of the study, the herd owner and 
the animal caretakers were instructed by the first author 
and the herd veterinarian to treat only animals that pre-
sented extensive generalised or localised skin lesions 
characterised by sebaceous exudation, epidermal ero-
sions and crusts.
Mortality rates
The number of pigs that died during the nursery period 
showing clinical signs of EE together with the total 
number (all possible causes) were recorded. Mortality 
rates were calculated for the entire batch.
Bacteriological culture and AST
Throughout the nursery period, a subset of pigs that 
died was necropsied in order to assess the possible 
cause of death. Skin swabs were collected from necrop-
sied pigs as well as non-treated live pigs with clinical 
signs of EE and submitted for bacteriological culture 
and AST. Both were performed using the same method 
as before  the initiation of the study (as described in 
the Herd and outbreaks description section). A subset 
of the S hyicus isolates obtained from those pigs were 
typed in order to determine whether any of the exfolia-
tive toxin-encoding genes were present (as described in 
the Herd and outbreaks description section).
Performance parameters
From each batch, 180 sows were randomly selected. 
The parity distribution of the selected sows from each 
farrowing batch (A–D) is  presented in online supple-
mentary appendix 1. On the day of weaning, 180 pigs 
were randomly selected from each sow batch (one pig 
per selected litter). All randomisations were performed 
by the random procedure of the Excel program (Excel 
2007, Microsoft Office, Washington, USA). All selected 
pigs were ear-tagged, so that they could be identified 
at the nursery units. This method of randomisation 
was performed to avoid differences in the number of 
pigs that originated from the different sow batches, 
and to ensure that the average parity distribution of 
the selected sows in each farrowing batch will closely 
resemble the parity distribution of the whole batch. 
Within each nursery unit, between four and six of the 
ear-tagged pigs were allocated per nursery pen in order 
to ensure that all nursery pens were filled with an equal 
number of ear-tagged pigs.
In order to obtain the ADG (g/pig/day), ear-tagged 
pigs were individually weighed at weaning (three weeks 
of age) and at the end of the nursery period (10 weeks of 
age). The ADG was computed as the difference between 
starting and final bodyweights (weight gain) divided by 
the number of days during the period. All pigs that died 
during the nursery period were weighed and their age 
was recorded. In this way, the individual ADG values of 
the dead pigs were considered to calculate the ADG of 
each batch.
Statistical analysis
With regard to the nursery mortality rates, the inclu-
sion of a minimum of 1800 pigs per farrowing batch 
allowed to detect with 95  per  cent certainty and 
80 per cent statistical power a difference of 1.7 per cent 
points between pigs of the NV and V sows batches. The 
number of ear-tagged pigs in each farrowing batch (180) 
allowed to assess a difference of 19 g (sd=65) in ADG 
with 95  per  cent certainty and 80  per  cent statistical 
power (IBM SPSS Sample Power V.3, Illinois, USA). The 
pig was considered as statistical unit. Morbidity and 
mortality constituted the primary outcome parameters, 
whereas weight gain and ADG constituted secondary 
parameters. Due to the allocation of the pigs originating 
from the NV sow farrowing batches in both N1 and N2, 
all the statistical analyses of the primary and secondary 
outcome parameters were first carried out by comparing 
batches A and C (separately and combined) between N1 
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and N2. In case there were no statistically significant 
differences between N1 and N2, the nursery unit was 
not included as a factor in the final models (see online 
supplementary appendix 2). Morbidity and mortality 
rates were analysed using binary logistic regression 
with vaccination status and farrowing batch as predic-
tors for the model. General linear mixed models were 
used to analyse bodyweights, weight gain and ADG 
with vaccination status (NV or V), and farrowing batch 
included as fixed factors and pen as a random vari-
able.26 Bodyweight at weaning was used as a covar-
iate in the analysis. Statistical results were considered 
significant when P values were ≤0.05 (two-sided test). 
The statistical package SPSS V.23.0 was used to analyse 
the data.
Results
Antimicrobial consumption and morbidity rates
The UDDpig/ADDpig ratios for the NV and V farrowing 
batches were 1.79 and 1.31, respectively. When taking 
into account each of the farrowing batches A, B, C and D 
individually, the UDDpig/ADDpig ratios were 1.79, 1.60, 
1.78 and 0.99, respectively. The total amount of ceft-
iofur used to treat the EE-affected pigs among the NV 
and V farrowing batches was 88,550 and 39,600 mg, 
respectively. For each of the farrowing batches A, B, C 
and D, this amount was 45,250, 22,480, 43,300 and 
17,120 mg, respectively.
In N2, comparisons between the NV and V batch-
es revealed that there were no significant differenc-
es regarding their contribution to the morbidity rates 
(P=0.139; Table  4). When the morbidity rates across 
N1 and N2 were compared, the V batches reached 
significantly lower morbidity rates compared with the 
NV batches (P=0.008; Table 4). Comparisons between 
individual batches (data not shown) revealed that each 
of batches B and D had significantly less EE-affected pigs 
compared with batches A and C (6.25 and 6.74 per cent 
versus 12.81 and 15.92  per  cent, respectively; overall 
P=0.000).
Mortality rates
The percentages and numbers of dead pigs according 
to their vaccination status are presented in Table 5. In 
N2 there were no significant differences between the 
NV and the V farrowing batches in their contribution 
to the number of dead pigs with clinical signs of EE, 
neither to the total number of dead pigs (P=0.928 and 
P=0.730, respectively). When mortality data from 
both N1 and N2 were combined, the V batches exhib-
ited significantly less pigs dying with clinical signs of 
EE and also total mortality than the NV batches (both 
P=0.000). Comparisons between individual batches 
(data not shown) revealed that each of batches B 
and D had significantly less dead pigs with clinical 
signs of EE compared with batches A and C (2.50 and 
2.67  per  cent versus 6.00 and 4.04  per  cent, respec-
tively; overall P=0.007). The same trend was observed 
for the total mortality rates, where each of batches B 
and D had significantly lower rates than batches A and 
C (3.41 and 4.46 per cent versus 7.25 and 6.88 per cent, 
respectively; overall P=0.000).
Bacteriological culture and AST
Eight out of 257 dead pigs from the NV batches (4/133 
from batch A and 4/124 from batch C) and 8/160 dead 
pigs from the V batches (5/68 from batch B and 3/92 
from batch D) were necropsied. Pathological findings 
showed pneumonia in the apical lung lobes (1/16), 
rhinitis (3/16), fibrinopurulent pericarditis and endo-
carditis (2/16), enteritis (4/16) and EE (7/16). The 
following bacteria were isolated from various organ 
sites: Pasteurella multocida from the lungs and the 
nasal conchae (3/16), Trueperella pyogenes from the 
lungs (1/16), Streptococcus suis from the heart (2/16), 
Escherichia coli from the spleen and the jejunum (4/16), 
and S hyicus and S chromogenes from the skin (7/16 and 
2/16, respectively).
Table 4: Per cent (number) of pigs with clinical signs of exudative 
epidermitis that received metaphylactic antimicrobial treatment (also 
representing morbidity rates)
Nursery unit NV V P value
Both units 14.36 (523/3643)A 6.50 (264/4061)B 0.008
N1 7.00 (255/3643) n/a n/a
N2 7.36 (268/3643) 6.50 (264/4061) 0.139
Rates were calculated according to the total number of animals included in the non-vaccinated 
(batches A and C) and vaccinated (batches B and D) farrowing batches upon transfer to the nursery 
units.
Vaccination status: NV (pigs originating from non-vaccinated sow farrowing batches) and V (pigs 
originating from vaccinated sow farrowing batches). Values with different superscripts within a row are 
significantly different (P<0.05).
n/a, non-applicable.
Table 5: Per cent (number) of dead pigs with clinical signs of exudative epidermitis together with the total number of pigs that died from all causes
Whole batch level/pigs with EE signs Whole batch level/overall mortality
Nursery unit NV V P value NV V P* value
Both units 5.02 (183/3643)A 2.59 (105/4061)B 0.000 7.05 (257/3643)A 3.94 (160/4061)B 0.000
N1 2.47 (90/3643) n/a n/a 3.29 (120/3643) n/a n/a
N2 2.55 (93/3643) 2.59 (105/4061) 0.928 3.76 (137/3643) 3.94 (160/4061) 0.730
The contribution of each nursery unit (N1 and N2) on the combined (both units) mortality rates between three and ten weeks of age is presented separately. All mortality rates were calculated according to the total 
number of animals included in the non-vaccinated (NV; batches A and C) and vaccinated (V; batches B and D) farrowing batches upon transfer to the nursery units.
Vaccination status: NV (pigs originating from non-vaccinated sow farrowing batches) and V (pigs originating from vaccinated sow farrowing batches). Values with different superscripts within a row are significantly 
different (P<0.05 and P*<0.05). The P value refers to the comparisons between the summaries of the NV (A–C) and V (B–D) batches concerning the pigs that died showing signs of EE and the P* value to the 
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In addition to the necropsies, skin swabs were col-
lected from 15 live pigs (eight from the NV batches and 
seven from the V batches). Then, S hyicus together with S 
chromogenes were isolated from 9/14 and 2/14 of those 
swabs, respectively. Table 2 presents the AST results per-
formed on all S hyicus isolates from necropsied and live 
pigs (n=16). When compared with the isolates before the 
initiation of the study, the isolates obtained during the 
study were resistant to the same antimicrobials; neverthe-
less, the percentages of resistant isolates declined. Typ-
ing was performed in 8/16 of those isolates. The results 
showed that 2/8 (from batches C and D), 1/8 (from batch 
C) and 4/8 (from batches B and C) isolates were positive 
for the exfoliative toxin-encoding genes exhA, exhB and 
exhC, respectively. In 1/8 (from batch A) isolates, no tox-
in-encoding genes were detected.
Performance parameters
Table  6 summarises all performance parameters, 
taking into account both nursery units. Over the entire 
nursery period, there were no significant differences 
between the pigs from the NV sow batches and the pigs 
of the V batches in terms of their weight gain and ADG 
(P=0.628 and P=0.131, respectively).
Discussion
The present study investigated whether autogenous 
vaccination of sows against S hyicus at the end of 
gestation was efficacious to control EE outbreaks in 
their offspring during the nursery period. Pigs origi-
nating from the V batches of sows had significantly 
lower morbidity and mortality rates than those from 
the NV batches. Apart from having lower percentages 
of pigs treated with antimicrobials against EE, when 
taking into account the UDDpig/ADDpig ratios, batches 
B and D exhibited reduced overdosing with ceftiofur 
compared with batches A and C. Given that after the 
initiation of the study all prophylactic antimicrobial 
treatments were ceased, those results suggest that 
metaphylactic antimicrobial treatments are not suffi-
cient to resolve such severe EE outbreaks without any 
additional control measures. Current results suggest 
that an autogenous vaccination of the sows can help in 
decreasing morbidity, mortality and antimicrobial use 
during EE outbreaks.
Nevertheless, the autogenous vaccination of the 
sows was not able to fully protect against EE in the pigs 
of the V sow batches, neither to fully prevent mortality 
in pigs with clinical signs of EE. The average mortality 
rate of 2.59 per cent in the V batches, attributed to pigs 
with clinical signs of EE, is considered to be higher than 
published average nursery mortality rates from herds 
with no apparent disease outbreaks (ranging between 
0.54 and 2.1 per cent).27 28 Possible explanations may 
include the insufficient duration of maternal immunity, 
the presence of different S hyicus strains producing dif-
ferent types of exfoliative toxins and the cocirculation 
of S chromogenes.
In the present study, the first clinical signs of EE oc-
curred approximately one week after weaning and the 
severity of the disease increased towards the third week 
of the nursery period. The rationale of vaccinating the 
gestating sows twice in the V batches was that mater-
nal antibody transfer to their piglets would be further 
enhanced so that protection against the EE outbreaks 
is extended towards the first three weeks of the nurs-
ery period. This approach was based on the fact that, 
in general, the half-life of maternal antibodies induced 
by natural infection in pigs is considered to be between 
11.3 and 20 days.29 However, the half-life of maternal 
anti-S hyicus antibodies has not yet been elucidated, 
and thus it is possible that in the present herd passively 
acquired immunity against S hyicus had already waned 
towards the third week of the nursery period. To further 
investigate the optimal vaccination scheme in field cas-
es with similar EE manifestation and severity, it would 
be interesting to compare autogenous vaccination effi-
cacy in farrowing batches where only sow vaccination 
is applied versus farrowing batches where only suckling 
pigs are vaccinated.
During the present study, the different S hyicus iso-
lates obtained were found to be positive for three dif-
ferent exfoliative toxin-encoding genes (exhA, exhB 
and exhC). Since the vaccine needed approximately 
two months to be produced and delivered to the herd, 
it was not feasible to utilise isolates from the farrow-
ing batches included in the study for its production. 
Instead, isolates obtained before  the initiation of the 
study were used. Given that all isolates sent for typing 
before the initiation of the study were exhB-positive 
Table 6 Performance parameters from three to ten weeks of age for the selected pigs originating from the non-vaccinated (NV; batches A and C) and 




A B C D
P value
A–C (NV) B–D (V)
P* valuen=180 n=180 n=180 n=180 n=360 n=360
Average bodyweight (kg) 3 5.03±1.12 5.46±1.09 5.12±1.08 5.50±1.16 0.673 5.09±1.10A 5.48±1.13B 0.000
10 23.91±4.24 25.81±4.42 24.18±4.45 24.71±4.84 0.051 24.07±4.36 25.15±4.70 0.643
Weight gain (kg) 3–10 18.89±3.79 20.32±3.84 19.06±3.98 19.21±4.25 0.055 18.99±3.90 19.66±4.12 0.628
ADG (g/pig/day) 3–10 356±72 376±71 353±74 356±79 0.321 354±73 364±76 0.131
Data from batches A and C were summarised together, taking into account both nursery units (N1 and N2). Data from batches B and D were also  summarised together (for N2). 
Vaccination status: NV (pigs originating from non-vaccinated sow farrowing batches) and V (pigs originating from vaccinated sow farrowing batches). Values with different superscripts within a row are significantly 
different (P<0.05 and P*<0.05). The P value refers to the comparisons between the individual farrowing batches and the P* value to the comparisons between the summaries of the NV (A–C) and V (B–D) batches.
†Average daily gain (ADG).
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(5/5), it was decided to use three of those isolates for 
the production of the autogenous vaccine. The fact that 
exhA-positive and exhC-positive isolates appeared to 
circulate in batches B, C and D of the study shows the 
difficulty of keeping autogenous vaccines updated ac-
cording to the different S hyicus strains circulating in a 
herd during different time periods. In case there was a 
possibility to continue following this herd over a longer 
period of time, then the aforementioned exhA-positive 
and exhC-positive isolates could be used to produce a 
more holistic vaccine in terms of the toxigenic isolates 
included. In this way, the protective efficacy of autoge-
nous vaccination could be further enhanced.
At this point it should be mentioned that apart from 
S hyicus, S chromogenes was also isolated from different 
farrowing batches both before and during the study. So 
far, there is no published clinical study mentioning the 
use of an autogenous vaccine against S chromogenes in 
cases of EE. Andresen et al24 showed that pigs inoculat-
ed with an exhB-positive S chromogenes strain developed 
clinical signs of EE. The currently available literature de-
scribes S hyicus as the primary pathogen provoking severe 
EE outbreaks and S chromogenes as a secondary patho-
gen.30 31 The above-mentioned factors, together with the 
fact that most of the swabs taken from live pigs before the 
initiation of the study yielded S hyicus (9/13) and not S 
chromogenes (1/13), supported the decision to create an 
autogenous vaccine by solely using the S hyicus isolates 
obtained. Nevertheless, it is not known to what extent the 
cocirculation of S chromogenes isolates exacerbated the 
severity of the EE outbreaks. In future studies conducted 
in herds facing EE outbreaks where both S hyicus and S 
chromogenes are isolated, it would be useful to investigate 
the efficacy of autogenous vaccines combining isolates 
from both species.
In the current study, the vaccine was produced using 
only the bacterial cell preparations and not the culture su-
pernatants. According to Wegener and Skov-Jensen32 ex-
foliative toxins can be purified from the culture superna-
tant and serve as a single protective antigen. It is possible 
that if the culture supernatant is additionally utilised in 
the production of autogenous vaccines against S hyicus, 
then improved vaccination results can be obtained. How-
ever, such choice should be considered with caution as a 
vaccine with a high toxoid content could lead to severe 
allergic reactions.33 Such side effects can be particularly 
devastating when gestating sows are vaccinated and have 
already been described by other authors.34 In the current 
study, there were no obvious clinical adverse effects in the 
vaccinated sows, as observed by the investigators and re-
ported by the herd owner and the herd veterinarian. The 
use of veterinary vaccines under the cascade regimen is 
a risk-based decision; nevertheless, the current European 
legislation does not oblige to formally measure possible 
vaccination-related adverse effects. Although every new 
commercial vaccine needs to be tested for efficacy and 
safety, there is not such requirement for the autogenous 
vaccines.35 For that reason, literature suggests that new 
batches of autogenous vaccines should be first tried in a 
limited number of animals before being used on a larger 
scale.35 36
The reason behind the dose imprecision differences 
in the metaphylactic ceftiofur treatment between the 
pigs of the NV and V sow batches might be attributed to 
the behaviour of the herd owner towards batches with 
higher morbidity and mortality rates. Similar behav-
iours have already been observed in other studies due 
to the perception that overdosing of antimicrobials in 
batches with high morbidity and mortality rates would 
achieve better results in a shorter period of time.18 Under 
the new legislations applied in countries such as Den-
mark, where the amount of antimicrobials prescribed 
is monitored in order to calculate herd ADDpig for their 
‘yellow card’ system,16 the further optimisation of the 
efficacy of vaccines against EE under field conditions is 
of undoubted importance.
To conclude, significantly reduced morbidity and 
mortality rates were observed in the pigs of the V sow 
batches compared with those from the NV batches. 
Additionally, lower quantities of metaphylactic an-
timicrobial treatment were used in the pigs of the V 
batches than in the NV batches, implying that autoge-
nous vaccination could serve as a non-antimicrobial 
way to control severe EE outbreaks. Nevertheless, ad-
ditional studies are necessary to investigate whether 
the efficacy of autogenous vaccines to achieve fur-
ther reductions in morbidity and mortality rates can 
be enhanced. During the optimisation of autogenous 
vaccines, it should be taken into account that vaccine 
performance depends also on many other predispos-
ing factors such as management practices, hygiene 
and housing conditions. The inherent disadvantages 
of the autogenous vaccines such as the long time pe-
riod needed for their production, the need to be kept 
updated according to the different strains that can cir-
culate during different time periods and the risk of side 
effects occurring in the vaccinated population should 
also be considered.
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